House Members Propose Primatene Mist Inventory Clearance Sale
This article was originally published in The Tan Sheet
The House Energy and Power Subcommittee July 18 will discuss draft legislation that would require EPA to allow sales of the remaining inventory of Armstrong Pharmaceutical’s CFC-propelled epinephrine inhalers, Primatene Mist.
You may also be interested in...
Lawmakers seek to restore the availability of Primatene Mist while the absence of an alternative OTC asthma remedy persists.
The only inhalers to treat asthma available after Dec. 31 will be prescription products.